Welcome to LookChem.com Sign In|Join Free
  • or
AKOS BB-9603 is a chemical compound with antifungal, anti-inflammatory, and antineoplastic properties. It is a potent inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), which plays a crucial role in the biosynthesis of pyrimidine nucleotides. AKOS BB-9603 has demonstrated potential as a therapeutic agent for various medical conditions, including cancer, autoimmune diseases, and fungal infections. Its multifaceted action and ability to target DHODH make it a promising candidate for the development of new drugs in the pharmaceutical industry.

228262-99-5

Post Buying Request

228262-99-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

228262-99-5 Usage

Uses

Used in Pharmaceutical Industry:
AKOS BB-9603 is used as an antifungal agent for its ability to inhibit the growth of fungi, making it a potential treatment for various fungal infections.
AKOS BB-9603 is used as an anti-inflammatory agent for its capacity to reduce inflammation, which can be beneficial in managing autoimmune diseases and other inflammatory conditions.
AKOS BB-9603 is used as an antineoplastic agent for its potential to inhibit the growth and proliferation of cancer cells, offering a new avenue for cancer treatment.
AKOS BB-9603 is used as a dihydroorotate dehydrogenase (DHODH) inhibitor for its ability to target this enzyme, which is essential for the biosynthesis of pyrimidine nucleotides, thereby disrupting the growth of certain types of cells, including cancer cells and certain fungi.
AKOS BB-9603 is used in drug development for its potential to be formulated into new therapeutic agents targeting a range of medical conditions, based on its diverse pharmacological properties.

Check Digit Verification of cas no

The CAS Registry Mumber 228262-99-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,2,6 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 228262-99:
(8*2)+(7*2)+(6*8)+(5*2)+(4*6)+(3*2)+(2*9)+(1*9)=145
145 % 10 = 5
So 228262-99-5 is a valid CAS Registry Number.

228262-99-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-amino-1-benzylimidazole-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-amino-1-benzyl-4-imidazolecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:228262-99-5 SDS

228262-99-5Relevant academic research and scientific papers

Nucleic acid related compounds. 136. Synthesis of 2-amino- and 2,6-diaminopurine derivatives via inverse-electron-demand Diels-Alder reactions

Lin, Xiaoyu,Robins, Morris J.

, p. 1029 - 1041 (2008/02/07)

Thermal inverse-electron-demand Diels-Alder reactions of 5-aminoimidazoles and 2,4,6-tris-(ethoxycarbonyl)-1,3,5-triazine (2) with spontaneous retro-Diels-Alder loss of ethyl cyanoformate and elimination of ammonia give 2,6-bis(ethoxycarbonyl)purines. A report that selective alkaline hydrolysis followed by acid-catalyzed decarboxylation gave 6-(ethoxycarbonyl)purine products was not in harmony with known reactions in purine chemistry. Our reinvestigation has shown that the 6-(ethoxycarbonyl) group undergoes preferential base-promoted hydrolysis, as expected, but regioselectivity for attack of hydroxide at the carbonyl group at C6 is not high (relative to hydrolysis of both C2 and C6 esters). The structure of 9-benzyl-2- (ethoxycarbonyl)purine was determined by X-ray crystallography and confirmed by Curtius rearrangement of the azidocarbonyl analogue to give 2-amino-6- benzylpurine. Acid-catalyzed decarboxylation of the 2,6-dicarboxylate formed during hydrolysis gave 9-benzylpurine, and Curtius rearrangement of 2,6-bis(azidocarbonyl)-9-benzylpurine gave 2,6-diamino-9-benzylpurine. Attempted applications of inverse-electron-demand Diels-Alder reactions of 2 with nucleoside derivatives were problematic.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 228262-99-5